Testing

Nikola Baumann, Ph.D., gives an overview of the new NASH-FibroTest available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing improves upon previous testing approaches, and what clinical action can be taken due to the results of this testing.

By Alyssa Frank • March 18, 2019

Mayo Clinic pathologists, researchers, and a wide spectrum of allied health staff are in National Harbor, Maryland for the 108th United States and Canadian Academy of Pathology Meeting. Visit us at booth #510 to discuss how our testing can integrate with your practice.

By mayocliniclabs • March 18, 2019

In February 2019, Mayo Clinic Laboratories announced one new test along with numerous reference value changes, obsolete tests, and algorithm changes.

By Emily Linginfelter • March 7, 2019

David Viswanatha, M.D., gives an overview of the NGS testing for myeloid malignancies available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing improves upon previous testing approaches, and what clinical action can be taken due to the results of this testing.

By Alyssa Frank • February 14, 2019

In January 2019, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

By Emily Linginfelter • February 12, 2019

The list of updates posted to mayocliniclabs.com during the month of January 2019 are now available.

By Andy Tofilon • February 11, 2019

Autoimmune neurological disorders can often be treated, sometimes with full restoration of function. However, because the symptoms mimic other conditions, autoimmune neurological disorders are frequently misdiagnosed, resulting in an irreversible loss of function.

By Barbara J. Toman • February 11, 2019

Ann Moyer, M.D., Ph.D., gives an overview of the inflammatory bowel disease primary immunodeficiency testing available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing improves upon previous testing approaches, and what clinical action can be taken due to the results of this testing.

By Emily Linginfelter • February 5, 2019

numares and Mayo Clinic Laboratories have announced a collaboration to develop clinical diagnostic tests that will measure clusters of risk factors as opposed to individual biomarkers. The unique testing will use nuclear magnetic resonance technology, focusing on cardiovascular disease, kidney disease and liver cancer—among a few other specific diseases.

By Gina Chiri-Osmond • February 5, 2019

In close collaboration with our logistics providers, we have determined that clients can now safely send all specimens to Rochester now that temperatures have moderated. Thank you for your patience and understanding.

By Andy Tofilon • January 30, 2019

John Lieske, M.D., gives an overview of the phospholipase A2 receptor antibodies testing available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing improves upon previous testing approaches, and what clinical action can be taken due to the results of this testing.

By Alyssa Frank • January 18, 2019

A movement disorder might be caused by the body’s immune system, which is meant to fight infections, suddenly attacking the brain. Fortunately, an “autoimmune movement disorder” can often be treated—once its cause is discovered.

By Christoph Bahn • January 17, 2019

In December 2018, Mayo Clinic Laboratories announced four new tests along with numerous reference value […]

By Emily Linginfelter • January 10, 2019